Literature DB >> 15522000

The influence of BCG immunisation on tuberculin reactivity and booster effect in adults in a country with a high prevalence of tuberculosis.

K Hizel1, I Maral, R Karakus, F Aktas.   

Abstract

The relationship of age and previous BCG vaccination with tuberculin skin test (TST) reactivity was investigated to assess the interpretation of TST results in the adult population of Turkey, where there is a high prevalence of tuberculosis and a routine BCG vaccination programme. The influences of age and BCG vaccine status on booster reaction were also evaluated. TST was applied (5 tuberculin units of purified protein derivative intradermally) to two healthy adult groups, namely 98 medical students and 187 elderly people in a retirement home. The TST was considered positive if an induration > or = 10 mm in diameter was produced. Subjects (41 elderly people and 39 students) with a reaction < 10 mm in diameter were retested 1 week later. There was no significant difference between the students (59.1%) and elderly subjects (58.8%) with respect to positive TST response. No influence of BCG scars on TST reactivity was observed in either group. The booster effect was seen more commonly in the elderly, but the presence of a BCG scar did not influence the booster effect in either group. It was concluded that a positive TST response and booster reaction in adults in high-prevalence countries may be caused by latent tuberculosis rather than previous vaccination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522000     DOI: 10.1111/j.1469-0691.2004.00970.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  7 in total

1.  Contact investigation after a fatal case of extensively drug-resistant tuberculosis (XDR-TB) in an aircraft, Germany, July 2013.

Authors:  Maria An der Heiden; Barbara Hauer; Lena Fiebig; Gisela Glaser-Paschke; Markus Stemmler; Claudia Simon; Sabine Rüsch-Gerdes; Andreas Gilsdorf; Walter Haas
Journal:  Euro Surveill       Date:  2017-03-23

2.  Tuberculin skin test and boosted reactions among newly employed healthcare workers: an observational study.

Authors:  Song Yee Kim; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Dongeun Yong; Hyun Sook Kim; Kyungwon Lee; Young Ae Kang
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

3.  Boosted reaction on two-step tuberculin skin test among military personnel in South Korea, a setting with an intermediate burden of tuberculosis and routine bacille Calmette-Guerin vaccination.

Authors:  Kyeongman Jeon; Sang-Hoon Ji; Soo-Yon Oh; Jin-Beom Lee; Hee-Jin Kim; Chang-Min Choi
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

4.  Two-step tuberculin skin testing in school-going adolescents with initial 0-4 millimeter responses in a high tuberculosis prevalence setting in South India.

Authors:  Maitreyi Murthy; Sumithra Selvam; Nelson Jesuraj; Sean Bennett; Mark Doherty; Harleen M S Grewal; Mario Vaz
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

5.  The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region.

Authors:  X Mariette; J Vencovsky; O Lortholary; J Gomez-Reino; M de Longueville; P Ralston; M Weinblatt; R van Vollenhoven
Journal:  RMD Open       Date:  2015-04-28

6.  Factors determining COVID-19 pneumonia severity in a country with routine BCG vaccination.

Authors:  K Aksu; T Naziroğlu; P Özkan
Journal:  Clin Exp Immunol       Date:  2020-09-17       Impact factor: 4.330

7.  Sensitivity, Specificity, and Safety of a Novel ESAT6-CFP10 Skin Test for Tuberculosis Infection in China: 2 Randomized, Self-Controlled, Parallel-Group Phase 2b Trials.

Authors:  Miao Xu; Wei Lu; Tao Li; Jingxin Li; Weixin Du; Qi Wu; Qiao Liu; Baodong Yuan; Jinbiao Lu; Xiaoyan Ding; Feng Li; Min Liu; Baowen Chen; Jiang Pu; Rongping Zhang; Xiuhong Xi; Rongguang Zhou; Zaoxian Mei; Ronghui Du; Lifeng Tao; Leonardo Martinez; Shuihua Lu; Guozhi Wang; Fengcai Zhu
Journal:  Clin Infect Dis       Date:  2022-03-01       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.